Hostname: page-component-78c5997874-dh8gc Total loading time: 0 Render date: 2024-11-06T09:05:34.527Z Has data issue: false hasContentIssue false

The challenges of managing rheumatic disease of the mitral valve in Jamaica*

Published online by Cambridge University Press:  29 December 2014

Sherard G. Little*
Affiliation:
Department of Surgery, Bustamante Hospital for Children, Kingston, Jamaica Department of Cardiothoracic Surgery, Department of Surgery, University Hospital of the West Indies, Jamaica
*
Correspondence to: S. Little, Chief of Paediatric Cardiac Surgery, The Bustamante Hospital for Children, Arthur Wint Drive, Kingston 5, Kingston, Jamaica. Tel: 876-968-0300; Fax: 876-754-2860. E-mail: [email protected]

Abstract

Between January, 2009 and December, 2013, 84 patients were identified who underwent isolated mitral valve surgery in Jamaica at The University Hospital of the West Indies and The Bustamante Hospital for Children. The most common pathology requiring surgery was rheumatic heart disease, accounting for 84% of the procedures performed. The majority of patients had regurgitation of the mitral valve (67%), stenosis of the mitral valve (22%), and mixed mitral valve disease (11%). The most common procedure performed was replacement of the mitral valve (69%), followed by mitral valve repair (29%). Among the patients, one underwent closed mitral commissurotomy. The choice of procedure differed between age groups. In the paediatric population (<18 years of age), the majority of patients underwent repair of the mitral valve (89%). In the adult population (18 years and above), the majority of patients underwent mitral valve replacement (93%). Overall, of all the patients undergoing replacement of the mitral valve, 89% received a mechanical valve prosthesis, whereas 11% received a bioprosthetic valve prosthesis. Of the group of patients who underwent mitral valve repair for rheumatic heart disease, 19% required re-operation. The average time between initial surgery and re-operation was 1.2 years. Rheumatic fever and rheumatic heart disease remain significant public health challenges in Jamaica and other developing countries. Focus must remain on primary and secondary prevention strategies in order to limit the burden of rheumatic valvulopathies. Attention should also be directed towards improving access to surgical treatment for young adults.

Type
Original Article
Copyright
© Cambridge University Press 2014 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

*

Presented at the Johns Hopkins All Children’s Heart Institute, 14th Annual International Symposium on Congenital Heart Disease, Saint Petersburg, Florida, United States of America, 15–18 February, 2014.

References

1.WHO. Rheumatic fever and rheumatic heart disease: Report of WHO Study Group, Technical Report Series No. 764, WHO, 1988.Google Scholar
2.Statistical Institute of Jamaica. Population and Housing Census, 2011. Retrieved February 8, 2014, from http://statinja.gov.jmGoogle Scholar
3.WHO Cardiovascular Diseases Unit. WHO programme for the prevention of rheumatic fever/rheumatic heart disease in 16 developing countries: report from Phase 1 (1986–1990). Bull World Health Organ 1992; 70: 213218.Google Scholar
4.Milliard-Bullock, D. The rheumatic fever and rheumatic heart disease control programme – Jamaica. West Indian Med J 2012; 61: 361364.Google Scholar
5.Scarlett, MD. Thirty-five years of cardiac surgery in Jamaica. West Indian Med J 2004; 53: 178183.Google Scholar